There are numerous stem cell types in the bone marrow. Specific stem cells of the hematopoietic lineage were originally identified as being CD34+. In this patent, a CD34-stem cell is claimed that produces growth factors capable of stimulating hematopoiesis.
This patent may be a really great candidate for developing since at first appearance it does not seem to be under commercialization.
The "modernization" of such old intellectual property may be very lucrative for biotech executives.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.